2021 New Mexico Statutes
Article 1 - General Provisions
Section 26-1-26 - Penalties.

A. Any person who knowingly violates any of the provisions of Subsection A, B, C, F, G or H of Section 26-1-3, Section 26-1-14, 26-1-16, 26-1-22 or 26-1-23 NMSA 1978 is guilty of a fourth degree felony and shall be punished by a fine of not less than one thousand dollars ($1,000) or more than five thousand dollars ($5,000) or by imprisonment for not less than one year or both.
B. Except as provided in Subsection A of this section, any person violating any of the provisions of the New Mexico Drug, Device and Cosmetic Act is guilty of a misdemeanor for the first offense and for second and subsequent offenses is guilty of a fourth degree felony.
History: 1953 Comp., § 54-6-51, enacted by Laws 1967, ch. 23, § 26; 1971, ch. 245, § 4; 1972, ch. 84, § 53; 1987, ch. 270, § 7.
The 1987 amendment, effective June 19, 1987, in Subsection A, updated the statutory references, deleted "a misdemeanor and shall be punished by a fine of not more than one thousand dollars ($1,000) or by imprisonment for not more than one year for the first offense and for second and subsequent offenses is guilty of" following "is guilty of," and added the language at the end of the subsection following "fourth degree felony"; and, in Subsection B, inserted "Device," deleted "petty" preceding "misdemeanor," and made a minor stylistic change.
Methaqualone. — The legislature has not specifically designated methaqualone as a "controlled substance" or "dangerous drug" under either the Controlled Substances Act or this article, but has authorized the board of pharmacy to add this substance by administrative regulation to the list of substances controlled under these acts. State v. Reams, 1981-NMCA-158, 98 N.M. 372, 648 P.2d 1185, aff'd in part, rev'd in part, 1982-NMSC-075, 98 N.M. 215, 647 P.2d 417.

Structure 2021 New Mexico Statutes

2021 New Mexico Statutes

Chapter 26 - Drugs and Cosmetics

Article 1 - General Provisions

Section 26-1-1 - Short title.

Section 26-1-2 - Definitions.

Section 26-1-3 - Prohibited acts.

Section 26-1-3.1 - Repealed.

Section 26-1-3.2 - Prescription drug donation.

Section 26-1-4 - Power to enjoin violations.

Section 26-1-5 - Penalty; exemptions.

Section 26-1-6 - Detection of drugs, devices or cosmetic believed adulterated, misbranded or counterfeit; condemnation; destruction or correction of defect; forfeiture and sale.

Section 26-1-7 - Attorney general or district attorney to institute prosecutions.

Section 26-1-8 - Minor violations of act; warnings authorized.

Section 26-1-9 - Addition of poisonous or deleterious substances; color additives.

Section 26-1-10 - Drug or device adulteration.

Section 26-1-11 - Drug or device; misbranding.

Section 26-1-12 - False advertising.

Section 26-1-13 - Packaging and labeling requirements; proprietary preparations.

Section 26-1-14 - New drugs and devices; prerequisites to sale, delivery or giving away; exceptions.

Section 26-1-15 - Dangerous drugs; veterinary use; limitations.

Section 26-1-16 - Dangerous drugs; conditions for sale; prescription refilling; limitations.

Section 26-1-16.1 - Opioids; requiring practitioners to obtain and review reports from the prescription monitoring program.

Section 26-1-17 - Testing laboratory.

Section 26-1-18 - Promulgating regulations; procedure.

Section 26-1-18.1 - Prescription drug prior authorization protocols.

Section 26-1-19 - Power to make inspections and secure samples.

Section 26-1-20 - Personnel.

Section 26-1-21 - Power of board to publish reports and disseminate information.

Section 26-1-22 - Unlawful means of obtaining dangerous drugs enumerated.

Section 26-1-23 - False statements; false pretenses; forgery of labels or prescriptions prohibited.

Section 26-1-24 - Cosmetics; misbranding.

Section 26-1-25 - Cosmetics; adulteration.

Section 26-1-26 - Penalties.